Holimed Pharmaceutical Private Limited
About Holimed Pharmaceutical Private Limited
Data last updated:
Holimed Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2017PTC317724. Its GSTIN is 07AAECH1911J1ZS (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahendra Singh Mehra and Jeevanti Mehra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 5 Djm – 303 2nd Floor C1 Block, Lsc Dwar, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.59 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹32,890 (net margin -2.8%) and EBITDA of -₹31,784 (EBITDA margin -2.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 5 Djm – 303 2nd Floor C1 Block, Lsc Dwar, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Holimed Pharmaceutical Private Limited
The main business activity of Holimed Pharmaceutical is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Holimed Pharmaceutical Private Limited FY 2025 filings available
Holimed Pharmaceutical Private Limited reported revenue of ₹11.59 Lakh (down 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Holimed Pharmaceutical Private Limited
Revenue fell 32% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 340% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Holimed Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹31,784 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹32,890 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Holimed Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Holimed Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Confiance Pharmaceuticals Private Limited | ₹11.67 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Madhubani, Bihar, India |
| Aushad Distributors Private Limited | ₹11.66 Lakh (FY 2024) | •••• | •••• | 34.0% | •••• | Mysore, Karnataka, India |
| Orcked Healthcare Private Limited | ₹11.66 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Allahabad, Uttar Pradesh, India |
| Radius Global Private Limited | ₹11.65 Lakh (FY 2025) | •••• | •••• | -51.0% | •••• | Ahmedabad, Gujarat, India |
| I-Oxin Pharma Private Limited | ₹11.64 Lakh (FY 2021) | •••• | •••• | -52.0% | •••• | Bahyander East, Maharashtra, India |
| Holimed Pharmaceutical Private Limited this company | ₹11.59 Lakh (FY 2024) | •••• | •••• | -32.0% | •••• | New Delhi, Delhi, India |
| Vertebra Lifesciences Private Limited | ₹11.59 Lakh (FY 2018) | •••• | •••• | •••• | Rampur, Uttar Pradesh, India | |
| Khushia1 Life Care Private Limited | ₹11.58 Lakh (FY 2017) | •••• | •••• | -2.0% | •••• | Alwar, Rajasthan, India |
| Snill Meds India Private Limited | ₹11.56 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Chennai, Tamil Nadu, India |
| R2pexcellent Private Limited | ₹11.53 Lakh (FY 2024) | •••• | •••• | 690.0% | •••• | Mallappally, Kerala, India |
| Multi Pharma Private Limited | ₹11.52 Lakh (FY 2025) | •••• | •••• | 25503.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Holimed Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Singh Mehra | Director | 06 Oct 2021 | 5 Years 0 Months | Current |
| Jeevanti Mehra | Director | 08 Sep 2025 | 1 Years 1 Months | Current |
Ownership and Shareholding of Holimed Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Holimed Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Holimed Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Nitin Sharma ceased to be Director on 24 Feb 2026.
Credit Ratings, Litigation & Regulatory Alerts for Holimed Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Holimed Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Holimed Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECH1911J1ZS | Delhi | Active | 26 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Holimed Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Holimed Pharmaceutical Private Limited
Holimed Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2017 (9+ years old) and is registered under CIN U24304DL2017PTC317724.
Holimed Pharmaceutical reported revenue of ₹11.59 Lakh for FY 2024 (down 32% YoY).
Holimed Pharmaceutical has 2 current directors:
- Mahendra Singh Mehra - Director
- Jeevanti Mehra - Director
Holimed Pharmaceutical reported a net loss of ₹32,890 (net margin -2.8%) and EBITDA of -₹31,784 (EBITDA margin -2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Holimed Pharmaceutical is 3% over three years. In the latest year (FY 2024) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Holimed Pharmaceutical is 07AAECH1911J1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of Holimed Pharmaceutical is U24304DL2017PTC317724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Holimed Pharmaceutical was incorporated on 18 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Holimed Pharmaceutical by revenue are Confiance Pharmaceuticals Private Limited, Aushad Distributors Private Limited, Orcked Healthcare Private Limited, Radius Global Private Limited, I-Oxin Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Nitin Sharma ceased to be Director on 24 Feb 2026. Jeevanti Mehra was appointed as Director on 08 Sep 2025. Jeevanti Mehra ceased to be Director on 06 Oct 2021. Holimed Pharmaceutical has 5 board changes on record in total.
The registered office of Holimed Pharmaceutical is at Plot No. 5 Djm – 303 2nd Floor C1 Block, Lsc Dwar, New Delhi, Delhi, India – 110058.